50 related articles for article (PubMed ID: 9744776)
1. Carboplatin dosing in the treatment of ovarian cancer: An NRG oncology group study.
Praiss AM; Miller A; Smith J; Lichtman SM; Bookman M; Aghajanian C; Sabbatini P; Backes F; Cohn DE; Argenta P; Friedlander M; Goodheart MJ; Mutch DG; Gershenson DM; Tewari KS; Wenham RM; Wahner Hendrickson AE; Lee RB; Gray H; Secord AA; Van Le L; O'Cearbhaill RE
Gynecol Oncol; 2023 Jul; 174():213-223. PubMed ID: 37229879
[TBL] [Abstract][Full Text] [Related]
2. Carboplatin dosage: prospective evaluation of a simple formula based on renal function.
Calvert AH; Newell DR; Gumbrell LA; O'Reilly S; Burnell M; Boxall FE; Siddik ZH; Judson IR; Gore ME; Wiltshaw E
J Clin Oncol; 2023 Oct; 41(28):4453-4454. PubMed ID: 37757592
[TBL] [Abstract][Full Text] [Related]
3. Prediction from creatinine clearance of thrombocytopenia and recommended dose in patients receiving (glycolato-O,O')-diammine platinum (II) (NSC 375101D).
Sasaki Y; Fukuda M; Morita M; Shinkai T; Eguchi K; Tamura T; Ohe Y; Yamada K; Kojima A; Nakagawa K
Jpn J Cancer Res; 1990 Feb; 81(2):196-200. PubMed ID: 2110134
[TBL] [Abstract][Full Text] [Related]
4. Generation of evidence-based carboplatin dosing guidelines for neonates and infants.
Barnett S; Makin G; Tweddle DA; Osborne C; Veal GJ
Br J Cancer; 2023 Nov; 129(11):1773-1779. PubMed ID: 37816842
[TBL] [Abstract][Full Text] [Related]
5. Area under the Curve-Based Dosing of Vancomycin in Critically Ill Patients Using 6-Hour Urine Creatinine Clearance Measurement.
Shahrami B; Najmeddin F; Ghaffari S; Najafi A; Rouini MR; Mojtahedzadeh M
Crit Care Res Pract; 2020; 2020():8831138. PubMed ID: 33425384
[TBL] [Abstract][Full Text] [Related]
6. Population Pharmacokinetics of Digoxin in Nonagenarian Patients: Optimization of the Dosing Regimen.
Salcedo-Mingoarranz AL; Medellín-Garibay SE; Barcia-Hernández E; García-Díaz B
Clin Pharmacokinet; 2023 Dec; 62(12):1725-1738. PubMed ID: 37816957
[TBL] [Abstract][Full Text] [Related]
7. Utilization of muscle area in an accurate prediction formula for renal function for patients with hepatocellular carcinoma.
Hayashi H; Shimizu A; Kubota K; Kitagawa N; Notake T; Masuo H; Yoshizawa T; Sakai H; Yasukawa K; Soejima Y
Asian J Surg; 2024 Feb; 47(2):893-898. PubMed ID: 37923599
[TBL] [Abstract][Full Text] [Related]
8. Carboplatin Dosing on the Basis of Renal Function: 30+ Years after Calvert.
Schwenk MH
Kidney360; 2024 Feb; 5(2):271-273. PubMed ID: 38233985
[No Abstract] [Full Text] [Related]
9. An Extension of Kish's Formula for Design Effects to Two- and Three-Stage Designs with Stratification.
Chen S; Rust K
J Surv Stat Methodol; 2017 Jun; 5(2):111-130. PubMed ID: 37583392
[TBL] [Abstract][Full Text] [Related]
10. Adjustment of creatinine clearance for carboplatin dosing in Calvert's formula and clinical efficacy for lung cancer.
Hatta T; Hase T; Hara T; Kimura T; Kojima E; Abe T; Horio Y; Goto Y; Ozawa N; Yogo N; Shibata H; Shimokata T; Oguri T; Yamamoto M; Yanagisawa K; Ando M; Ando Y; Kondo M; Ishii M; Hasegawa Y
Cancer Med; 2023 Aug; 12(15):15955-15969. PubMed ID: 37351560
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.
Gao B; Lu Y; Nieuweboer AJM; Xu H; Beesley J; Boere I; de Graan AM; de Bruijn P; Gurney H; J Kennedy C; Chiew YE; Johnatty SE; Beale P; Harrison M; Luccarini C; Conroy D; Mathijssen RHJ; R Harnett P; Balleine RL; Chenevix-Trench G; Macgregor S; de Fazio A
Sci Rep; 2018 Jan; 8(1):1508. PubMed ID: 29367611
[TBL] [Abstract][Full Text] [Related]
12. Superselective Intra-arterial Infusion Chemotherapy with Nedaplatin for Oral Cancer: A Pharmacological Study of the Dose Clearance.
Miyake M; Ohbayashi Y; Iwasaki A; Sawai F; Toyama Y; Nishiyama Y
J Maxillofac Oral Surg; 2015 Sep; 14(3):616-23. PubMed ID: 26225053
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy dosing in overweight and obese patients with cancer.
Lyman GH; Sparreboom A
Nat Rev Clin Oncol; 2013 Aug; 10(8):451-9. PubMed ID: 23856744
[TBL] [Abstract][Full Text] [Related]
14. Comparison of two methods for carboplatin dosing in children with retinoblastoma.
Allen S; Wilson MW; Watkins A; Billups C; Qaddoumi I; Haik BH; Rodriguez-Galindo C
Pediatr Blood Cancer; 2010 Jul; 55(1):47-54. PubMed ID: 20486170
[TBL] [Abstract][Full Text] [Related]
15. Determination of carboplatin dose by area under the curve in combination chemotherapy for senile non-small cell lung cancer.
Yin T; Liu Q; Hu C
J Huazhong Univ Sci Technolog Med Sci; 2007 Dec; 27(6):710-2. PubMed ID: 18231750
[TBL] [Abstract][Full Text] [Related]
16. Estimation of glomerular filtration rate in cancer patients.
Wright JG; Boddy AV; Highley M; Fenwick J; McGill A; Calvert AH
Br J Cancer; 2001 Feb; 84(4):452-9. PubMed ID: 11207037
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetically guided administration of chemotherapeutic agents.
van den Bongard HJ; Mathôt RA; Beijnen JH; Schellens JH
Clin Pharmacokinet; 2000 Nov; 39(5):345-67. PubMed ID: 11108434
[TBL] [Abstract][Full Text] [Related]
18. Prediction of carboplatin clearance calculated by patient characteristics or 24-hour creatinine clearance: a comparison of the performance of three formulae.
Okamoto H; Nagatomo A; Kunitoh H; Kunikane H; Watanabe K
Cancer Chemother Pharmacol; 1998; 42(4):307-12. PubMed ID: 9744776
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
